Table 1.
Variable | Manual compression (n = 4095) | Any closure device (n = 7320) | p‐value |
---|---|---|---|
Female | 1482 (36.2%) | 2435 (33.3%) | < 0.002 |
Male | 2613 (63.8%) | 4885 (66.7%) | |
Age, years | 66.1 ± 12.4 | 64.7 ± 12 | < 0.001 |
White | 3807 (93.0%) | 6567 (89.9%) | < 0.001 |
Black | 241 (5.9%) | 593 (8.1%) | < 0.001 |
Asian | 25 (0.6%) | 103 (1.4%) | < 0.001 |
Body mass index, kg/m2 | 30 ± 9 | 30.8 ± 7.3 | < 0.001 |
Diabetes mellitus | 1784 (43.6%) | 3266 (44.6%) | 0.280 |
Hypertension | 3383 (82.6%) | 6095 (83.3%) | 0.377 |
Hyperlipidemia | 3167 (77.4%) | 5818 (79.5%) | 0.008 |
Prior stroke | 658 (16.1%) | 859 (11.7%) | < 0.001 |
Peripheral vascular disease | 773 (18.9%) | 1038 (14.2%) | < 0.001 |
Prior PCI | 1799 (43.9%) | 3484 (47.6%) | < 0.001 |
Prior CABG | 874 (21.3%) | 1547 (21.1%) | 0.812 |
Chronic lung disease | 791 (19.3%) | 1070 (14.6%) | < 0.001 |
End‐stage renal disease | 219 (5.3%) | 421 (5.8%) | 0.373 |
Cardiac arrest | 223 (5.4%) | 143 (2.0%) | < 0.001 |
ST‐elevation myocardial infarction | 1256 (30.7%) | 1385 (18.9%) | < 0.001 |
Non‐ST‐elevation myocardial infarction | 1273 (31.1%) | 2056 (28.1%) | < 0.010 |
Glycoprotein IIb/IIIa inhibitor | 1074 (26.2%) | 744 (10.2%) | < 0.001 |
Note: Values are mean ± SD or n (%). Abbreviations: CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention.